These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 207777)

  • 1. Immunosuppressive activity of antibody directed against endogenous C-type virus interferes with early events of the immune response.
    Schumann G; Moroni C
    J Immunol; 1978 Jun; 120(6):1913-6. PubMed ID: 207777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by leukemia viruses. Effect of Friend leukemia virus on humoral immune competence of leukemia-resistant C57BL/6 mice.
    Ceglowski WS; Campbell BP; Friedman H
    J Immunol; 1975 Jan; 114(1 Pt 1):231-6. PubMed ID: 1089712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo immune response suppression by the supernatant from concanavalin A-activated spleen cells.
    Reinertsen JL; Steinberg AD
    J Immunol; 1977 Jul; 119(1):217-22. PubMed ID: 326957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression by spleen cells from Moloney leukemia. III. Evidence for a suppressor cell that is not the leukemic, virus-producing cell.
    Cerny J; Grinwich KD; Stiller RA
    J Immunol; 1977 Sep; 119(3):1097-101. PubMed ID: 330747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of C-type viral leukemogenesis. I. Correlation of in vitro lymphocyte blastogenesis to viremia and leukemia.
    Lee JC; Ihle JN
    J Immunol; 1979 Nov; 123(5):2351-8. PubMed ID: 90708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression.
    Haran-Ghera N; Ben-Yaakov M; Peled A
    J Immunol; 1977 Feb; 118(2):600-6. PubMed ID: 320261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An approach to C-type virus immunoprevention of spontaneously occurring tumors in laboratory mice.
    Kelloff GJ; Peters RL; Donahoe RM; Ghazzouli I; Sass B; Nims RM; Huebner RJ
    Cancer Res; 1976 Feb; 36(2 pt 2):622-30. PubMed ID: 175922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression of humoral immunity to sheep erythrocytes in vitro by Friend virus leukemic spleen cells: induction of resistance by statolon.
    Weislow OS; Wheelock EF
    J Immunol; 1975 Jan; 114(1 Pt 1):211-5. PubMed ID: 1089711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppression by 334C murine leukemia virus: viral specificity and the activation of immunosuppressive effects during cloned viral leukemogenesis.
    Robinson MK; Manly KF; Evans MJ
    J Immunol; 1980 Mar; 124(3):1022-7. PubMed ID: 6244346
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic factors infuencing mouse type-C RNA virus induction by naturally occurring B cell mitogens.
    Phillips SM; Stephenson JR; Aaronson SA
    J Immunol; 1977 Feb; 118(2):662-6. PubMed ID: 190319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular basis of a unique tumor antigen of radiation leukemia virus-induced leukemia B6RV2: its relation to MuLV gp70 of xenotropic class.
    Nakayama E; Uenaka A; DeLeo AB; Stockert E; Obata Y; Ueda R; Inui Y
    J Immunol; 1986 May; 136(9):3502-7. PubMed ID: 3007622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effects of rabbit anti-mouse brain serum on theta bearing lymphocytes of AKR mice.
    Filppi JA; Rheins MS; Pierre RL
    Immunology; 1975 Apr; 28(4):659-68. PubMed ID: 1097331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of immune response in allogeneic mixed spleen cell cultures. I. Influence of I-region on the generation of suppressor cells.
    Kim YT; Schwartz A; Moody C; Siskind GW; Weksler ME
    J Immunol; 1980 Oct; 125(4):1724-9. PubMed ID: 6447730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syngeneic monoclonal antibodies to B16 melanoma viral antigens.
    Rappaport I; Alterman AL; Braverman S; Stackpole CW
    Cancer Res; 1987 Oct; 47(20):5391-6. PubMed ID: 3652042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the immunoglobulin heavy chain locus on expression of the VK1GAC light chain.
    Fulton RJ; Davie JM
    J Immunol; 1984 Jul; 133(1):465-70. PubMed ID: 6427345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.